Literature DB >> 392093

Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.

A Beaulieu, F P Quismorio, R C kitridou, G J Friou.   

Abstract

Crithidia luciliae, a hemoflagellate, was used in an immunofluorescent procedure to assay for antibodies to ds-DNA and their capacity to fix complement. Positive reactions with this method were limited to systemic lupus erythematosus patients, and sensitivity was comparable to the DNA binding assay. Complement fixing activity of antibodies to ds-DNA in 45 sera was determined using kinetoplast ds-DNA of Crithidia luciliae and an antiserum to C3. Complement fixing antibodies to ds-DNA were found in nearly all patients with documented active renal involvement and absent in nearly all patients with no, or inactive renal involvement.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 392093

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  DNA antibodies with and without complement-binding ability.

Authors:  A M Teppo; P Kurki; T Helve; O Wegelius
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

2.  Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.

Authors:  R P Taylor; B S Andrews; K W Morley; T Conlon
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

3.  Low-dose procainamide: low risk of complications with long-term use.

Authors:  C van Pham; J Noguchi; F P Quismorio; L J Haywood
Journal:  J Natl Med Assoc       Date:  1983-07       Impact factor: 1.798

4.  Measurement of anti-DNA antibodies: a reappraisal using five different methods.

Authors:  D A Isenberg; C Dudeney; W Williams; I Addison; S Charles; J Clarke; A Todd-Pokropek
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

5.  Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity.

Authors:  C G Mackworth-Young; J K Chan; C C Bunn; G R Hughes; A E Gharavi
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

6.  Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice.

Authors:  A C Horsfall; R Howson; P Silveira; D G Williams; A G Baxter
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

7.  Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology.

Authors:  M Okamura; Y Kanayama; K Amastu; N Negoro; S Kohda; T Takeda; T Inoue
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

8.  Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.

Authors:  R P Taylor; C Horgan; M Hooper; J Burge
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.